Pharmacological treatments of Chinese herbal medicine for irritable bowel syndrome in adults: A network meta-analysis of randomized controlled trials.
<h4>Introduction</h4>Plenty of clinical studies have suggested the value of Chinese herbal medicine (CHM) for patients with irritable bowel syndrome (IBS), but their efficacy and safety have not been systematically concluded yet. This article aimed to compare and rank the therapeutic eff...
Enregistré dans:
Auteurs principaux: | Yun-Bo Wu, Yun-Kai Dai, Ling Zhang, Huai-Geng Pan, Wei-Jing Chen, Ru-Liu Li, Ling Hu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/75545b6658f247e0b4a34b76a3b90034 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Effectiveness of Non-Pharmacological Interventions for Irritable Bowel Syndrome: A Systematic Review
par: Florent Amsallem, et autres
Publié: (2021) -
Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
par: Xiufang Cui, et autres
Publié: (2021) -
Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial
par: Ya Zheng, et autres
Publié: (2021) -
Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trial
par: Liang Zheng, et autres
Publié: (2021) -
The fecal mycobiome in patients with Irritable Bowel Syndrome
par: A. Das, et autres
Publié: (2021)